Both in Pharmaceuticals
Acurx Pharmaceuticals vs Dermata Therapeutics
Over the past year ACXP returned −69.5% and DRMA returned −78.3%; their daily moves had a correlation of 0.09.
ACXP −69.5% DRMA −78.3%Growth of $1, one year, split-adjusted
| Metric | ACXP | DRMA |
|---|---|---|
| Price | $1.31 | $1.13 |
| Market cap | $5.6M | $5.6M |
| Today | −2.61% | +0.89% |
| 1 month | −9.4% | −15.7% |
| 6 months | −62.7% | −0.9% |
| Year to date | −47.6% | −51.3% |
| 1 year | −67.8% | −78.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.7M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.3% | 85.6% |
| Short % of float | 3.3% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).